FIELD: chemistry.
SUBSTANCE: invention relates to analytical chemistry and provides a method for quantitative determination of aminocaproic acid (ACA) when combined with copolymer of 2-methyl-5-vinylpyridine and N-vinylpyrrolidone (CP) in various ready dosage forms, such as, for example, nasal drops or sprays. That is ensured by preparing calibration solutions of ACA of pharmacopoeial quality with concentrations the values of which are at the limits of tolerable deviations, as well as in the area of impermissible deviations. Accumulation of ACA is carried out by reversed-phase HPLC in an ion-pair version on a column with length of 250 mm and an inner diameter of 4.6 mm, filled with a fixed phase formed by spherical particles of silicon dioxide with size of 5 mcm, modified octadecylsilane in a gradient mode, mobile phase A contains (1 % H3PO4+10 mmol PSNa+15 mmol K2NRA4 in H2O): methanol in ratio of 70:30, and mobile phase B is methanol. ACA detection is carried out spectrophotometrically at wavelength of 210 nm and calculating arithmetic mean values of area under ACA curve (AUC) with subsequent approximation of linear function to AUC=kcACA to calculate coefficient k. Drug solution is diluted with mobile phase A to 0.5–5 mg/ml, chromatographed at least 3 times. After the samples are analyzed, a conclusion is made on the compliance of the preparation with the requirements for the content of ACA.
EFFECT: invention provides rapidness of analysis, as well as reduced labor and cost of quantitative determination of ACA.
1 cl, 5 dwg, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
COMPLEX NASAL SPRAY BASED ON AMINOCAPROIC ACID AND A COPOLYMER OF 2-METHYL-5-VINYLPYRIDINE AND N-VINYLPYRROLIDONE | 2017 |
|
RU2662089C1 |
USE OF AMINOCAPROIC ACID-BASED SPRAY AND COPOLYMER OF 2-METHYL-5-VINYLPYRIDINE AND N-VINYLPYRROLIDONE | 2017 |
|
RU2669811C1 |
ANTIVIRAL AND IMMUNOMODULATING COMBINATION OF AMINOCAPROIC ACID AND COPOLYMER OF 2-METHYL-5-VINYLPYRIDINE AND N-VINYLPYRROLIDONE | 2017 |
|
RU2669810C1 |
METHOD OF PRODUCING BRANCHED OLIGOHEXAMETHYLENE GUANIDINE SALTS HAVING DEGREE OF PURITY SUFFICIENT FOR USE THEREOF AS PHARMACEUTICAL SUBSTANCE | 2019 |
|
RU2729421C1 |
METHOD FOR QUANTITATIVE DETERMINATION OF TAURIN AND ALLANTOINE PRESENT TOGETHER BY HPLC | 2017 |
|
RU2643312C1 |
COPOLYMERS OF 2-METHYL-5-VINYL-PYRIDINE AND N-VINYL PYRROLIDONE, HAVING PHAGOCYTOSIS ACTIVATOR PROPERTIES | 2010 |
|
RU2430933C1 |
TEST SYSTEM BASED ON CONJUGATES “POLYMERIC MICROSPHERE-THYROGLOBULIN” FOR EXPRESS DIAGNOSTICS OF AUTOIMMUNE THYROID DISORDERS | 2017 |
|
RU2657834C1 |
N-VINYLPYRROLIDONE BASED COPOLYMERS | 2010 |
|
RU2415876C1 |
COPOLYMERS OF 4-VINYLPYRIDINE OR 2-METHYL-5-VINYLPYRIDINE AND N-VINYLPYRROLIDONE WITH TERMINAL CYANOVALERIC ACID RESIDUE AND USE THEREOF TO TREAT PNEUMOCONIOSIS | 2014 |
|
RU2550820C1 |
N-VINYLPYRROLIDONE-BASED COPOLYMERS IN FORM OF PHARMACEUTICALLY ACCEPTABLE SALTS OF ACIDS | 2013 |
|
RU2533113C1 |
Authors
Dates
2019-09-13—Published
2018-09-13—Filed